Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus - PubMed (original) (raw)
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
S Müller et al. EMBO J. 1998.
Abstract
The PML protein, identified first as part of the oncogenic PML-RARalpha chimera in acute promyelocytic leukemia (APL), concentrates within discrete subnuclear structures, corresponding to some types of nuclear bodies. These structures are disrupted in APL cells, and retinoic acid (RA) can trigger their reorganization, correlating with its therapeutic effect in this type of leukemia. Recently, arsenic trioxide (As2O3) was identified as a potent antileukemic agent which, similarly to RA, induces complete remissions in APL patients. Here we show that, in APL cells, As2O3 triggers rapid degradation of PML-RARalpha and provokes the restoration of intact nuclear bodies. In non-APL cells, the ubiquitin-like protein SUMO-1 is covalently attached to a subset of wild-type PML in a reversible and phosphorylation-dependent manner. The unmodified form of PML is found in the soluble nucleoplasmic fraction, whereas the SUMO-1-polymodified forms of PML are compartmentalized exclusively in the PML nuclear bodies. As2O3 administration strikingly increases the pool of SUMO-1-PML conjugates that, subsequently, accumulate in enlarged nuclear bodies. In contrast to PML-RARalpha, the overall amount of PML seems to remain unaltered up to 36 h following As2O3 treatment. These findings indicate that the conjugation of PML with SUMO-1 modulates its intracellular localization and suggest that post-translational modification by SUMO-1 may be more generally involved than previously suspected in the targeting of proteins to distinct subcellular structures. They provide additional evidence that the role of 'ubiquitin-like' post-translational modification is not limited to a degradation signal.
Similar articles
- PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann OG, Ruthardt M. Sternsdorf T, et al. Mol Cell Biol. 1999 Jul;19(7):5170-8. doi: 10.1128/MCB.19.7.5170. Mol Cell Biol. 1999. PMID: 10373566 Free PMC article. - Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honoré N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de Thé H. Lallemand-Breitenbach V, et al. J Exp Med. 2001 Jun 18;193(12):1361-71. doi: 10.1084/jem.193.12.1361. J Exp Med. 2001. PMID: 11413191 Free PMC article. - Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z, Miao Y, Zhu Y, Shi Y, Zhu J, Huang H, Yao X. Fu C, et al. Oncogene. 2005 Aug 18;24(35):5401-13. doi: 10.1038/sj.onc.1208714. Oncogene. 2005. PMID: 15940266 - Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission.
Zhu J, Lallemand-Breitenbach V, de Thé H. Zhu J, et al. Oncogene. 2001 Oct 29;20(49):7257-65. doi: 10.1038/sj.onc.1204852. Oncogene. 2001. PMID: 11704854 Review. - The promyelocytic leukemia nuclear body: sites of activity?
Eskiw CH, Bazett-Jones DP. Eskiw CH, et al. Biochem Cell Biol. 2002;80(3):301-10. doi: 10.1139/o02-079. Biochem Cell Biol. 2002. PMID: 12123283 Review.
Cited by
- Daxx mediated histone H3.3 deposition on HSV-1 DNA restricts genome decompaction and the progression of immediate-early transcription.
Roberts APE, Orr A, Iliev V, Orr L, McFarlane S, Yang Z, Epifano I, Loney C, Rodriguez MC, Cliffe AR, Conn KL, Boutell C. Roberts APE, et al. bioRxiv [Preprint]. 2024 Aug 15:2024.08.15.608064. doi: 10.1101/2024.08.15.608064. bioRxiv. 2024. PMID: 39185184 Free PMC article. Preprint. - Crosstalk between SUMOylation and other post-translational modifications in breast cancer.
Wei B, Yang F, Yu L, Qiu C. Wei B, et al. Cell Mol Biol Lett. 2024 Aug 10;29(1):107. doi: 10.1186/s11658-024-00624-3. Cell Mol Biol Lett. 2024. PMID: 39127633 Free PMC article. Review. - History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.
Bercier P, de Thé H. Bercier P, et al. Cancers (Basel). 2024 Mar 29;16(7):1351. doi: 10.3390/cancers16071351. Cancers (Basel). 2024. PMID: 38611029 Free PMC article. Review. - PML nuclear bodies: new players in familial amyotrophic lateral sclerosis-frontotemporal dementia?
Goswami A, Carra S. Goswami A, et al. Neural Regen Res. 2024 Sep 1;19(9):1875-1876. doi: 10.4103/1673-5374.391183. Epub 2023 Dec 21. Neural Regen Res. 2024. PMID: 38227505 Free PMC article. No abstract available. - Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC.
Dong D, Du Y, Fei X, Yang H, Li X, Yang X, Ma J, Huang S, Ma Z, Zheng J, Chan DW, Shi L, Li Y, Irving AT, Yuan X, Liu X, Ni P, Hu Y, Meng G, Peng Y, Sadler A, Xu D. Dong D, et al. Nat Commun. 2023 Dec 20;14(1):8465. doi: 10.1038/s41467-023-43945-1. Nat Commun. 2023. PMID: 38123560 Free PMC article.
References
- Genomics. 1997 Mar 1;40(2):362-6 - PubMed
- Biochem Biophys Res Commun. 1996 May 6;222(1):178-80 - PubMed
- Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3978-83 - PubMed
- EMBO J. 1997 Apr 1;16(7):1519-30 - PubMed
- Biochem J. 1997 Jul 15;325 ( Pt 2):325-30 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources